Transcription of p21WAF1/CDKN1A KR-POK Interacts with p53 and Represses Its Ability to Activate

Transcriptional regulation by p53 is thought to play a role in its ability to suppress tumorigenesis. However, there remain gaps in understanding about how p53 regulates transcription and how disrupting this function may promote cancer. Here we report a role in these processes for the kidney cancer–related gene KR-POK (ZBTB7C), a POZ domain and Kr€ uppel-like zinc finger transcription factor that we found to physically interact with p53. Murine embryonic fibroblasts isolated from genetically deficient mice (Kr-pok / MEFs) exhibited a proliferative defect relative to wild-type mouse embryonic fibroblasts (MEF). The zinc finger domain of Kr-pok interacted directly with the DNA binding and oligomerization domains of p53. This interaction was essential for Kr-pok to bind the distal promoter region of the CDKN1A gene, an important p53 target gene encoding the cell-cycle regulator p21WAF1, and to inhibit p53-mediated transcriptional activation of CDKN1A. Kr-pok also interacted with the transcriptional corepressors NCoR and BCoR, acting to repress histone H3 and H4 deacetylation at the proximal promoter region of the CDKN1A gene. Importantly, Kr-pok / MEFs displayed an enhancement in CDKN1A transactivation by p53 during the DNA damage response, without any parallel changes in transcription of either the p53 or Kr-pok genes themselves. Furthermore, Kr-pok promoted cell proliferation in vitro and in vivo, and its expression was increased in more than 50% of the malignant human kidney cancer cases analyzed. Together, our findings define KR-POK as a transcriptional repressor with a pro-oncogenic role that relies upon binding to p53 and inhibition of its transactivation function. Cancer Res; 72(5); 1137–48. 2012 AACR.

[1]  Matthew D. Smith,et al.  p53 binds to and is required for the repression of Arf tumor suppressor by HDAC and polycomb. , 2011, Cancer research.

[2]  Hongbin Song,et al.  FBI-1 functions as a novel AR co-repressor in prostate cancer cells , 2011, Cellular and Molecular Life Sciences.

[3]  Ramnik J. Xavier,et al.  Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor. , 2010, Blood.

[4]  J. Biegel,et al.  ZNF238 is expressed in postmitotic brain cells and inhibits brain tumor growth. , 2010, Cancer research.

[5]  D. Koh,et al.  A Novel POK Family Transcription Factor, ZBTB5, Represses Transcription of p21CIP1 Gene* , 2009, The Journal of Biological Chemistry.

[6]  Chae-Ok Yun,et al.  ZBTB2, a Novel Master Regulator of the p53 Pathway* , 2009, The Journal of Biological Chemistry.

[7]  S. Roychoudhury,et al.  DNA damage induced p53 downregulates Cdc20 by direct binding to its promoter causing chromatin remodeling , 2009, Nucleic acids research.

[8]  A. Gartel.  p21WAF1/CIP1 and cancer: A shifting paradigm? , 2009, BioFactors.

[9]  H. Lenz,et al.  Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage , 2008, Nucleic acids research.

[10]  J. Delrow,et al.  Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation , 2008, The EMBO journal.

[11]  James M. Roberts,et al.  CDK Inhibitors : Cell Cycle Regulators and Beyond , 2008 .

[12]  J. Costoya.  Functional analysis of the role of POK transcriptional repressors. , 2007, Briefings in functional genomics & proteomics.

[13]  I. Shih,et al.  A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival , 2006, Proceedings of the National Academy of Sciences.

[14]  J. Daniel,et al.  POZ for effect--POZ-ZF transcription factors in cancer and development. , 2006, Trends in cell biology.

[15]  S. Puri,et al.  The Polycystic Kidney Disease-1 Gene Is a Target for p53-mediated Transcriptional Repression* , 2006, Journal of Biological Chemistry.

[16]  K. Basso,et al.  BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells , 2005, Nature Immunology.

[17]  Xiaolong Liu,et al.  The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection , 2005, Nature Immunology.

[18]  Yi Zhang,et al.  The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment , 2005, Nature.

[19]  P. Pandolfi,et al.  Role of the proto-oncogene Pokemon in cellular transformation and ARF repression , 2005, Nature.

[20]  Ryan T. Phan,et al.  The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells , 2004, Nature.

[21]  C. Zahnow,et al.  Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. , 2004, Cancer cell.

[22]  P. Pandolfi,et al.  Essential role of Plzf in maintenance of spermatogonial stem cells , 2004, Nature Genetics.

[23]  A. Murray,et al.  Recycling the Cell Cycle Cyclins Revisited , 2004, Cell.

[24]  S. Benchimol,et al.  Transcriptional repression mediated by the p53 tumour suppressor , 2003, Cell Death and Differentiation.

[25]  Xin Lu,et al.  Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.

[26]  Antony M. Carr,et al.  The evolution of diverse biological responses to DNA damage: insights from yeast and p53 , 2001, Nature Cell Biology.

[27]  P. Pandolfi,et al.  Plzf regulates limb and axial skeletal patterning , 2000, Nature Genetics.

[28]  D. Notterman,et al.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. , 2000, Genes & development.

[29]  Y. Nakamura,et al.  The role of p53-target genes in human cancer. , 2000, Critical reviews in oncology/hematology.

[30]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[31]  A. Levine,et al.  Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. , 1999, Genes & development.

[32]  E. Koonin,et al.  Fold prediction and evolutionary analysis of the POZ domain: structural and evolutionary relationship with the potassium channel tetramerization domain. , 1999, Journal of molecular biology.

[33]  K. Kinzler,et al.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.

[34]  S. Inoue,et al.  Role of the histone deacetylase complex in acute promyelocytic leukaemia , 1998, Nature.

[35]  M. Bartelmann,et al.  APM‐1, a novel human gene, identified by aberrant co‐transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ‐zinc finger protein with growth inhibitory activity , 1998, The EMBO journal.

[36]  Bert Vogelstein,et al.  Cell-cycle arrest versus cell death in cancer therapy , 1997, Nature Medicine.

[37]  K. Struhl,et al.  Repression by Ume6 Involves Recruitment of a Complex Containing Sin3 Corepressor and Rpd3 Histone Deacetylase to Target Promoters , 1997, Cell.

[38]  S. Schreiber,et al.  Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase , 1997, Cell.

[39]  C. Glass,et al.  A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression , 1997, nature.

[40]  S. Baylin,et al.  HIC1 hypermethylation is a late event in hematopoietic neoplasms. , 1997, Cancer research.

[41]  B. Howard,et al.  Inhibition of Cyclin-dependent Kinases. Waf1 Retards S-phase Progression Primarily By , 1997 .

[42]  K. Kinzler,et al.  p21 is necessary for the p53-mediated G1 arrest in human cancer cells. , 1995, Cancer research.

[43]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[44]  H. Tilly,et al.  LAZ3, a novel zinc–finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas , 1993, Nature Genetics.

[45]  A. Zelent,et al.  Fusion between a novel Krüppel‐like zinc finger gene and the retinoic acid receptor‐alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. , 1993, The EMBO journal.

[46]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[47]  E. Koonin,et al.  A family of DNA virus genes that consists of fused portions of unrelated cellular genes. , 1992, Trends in biochemical sciences.